Skip to main content
. 2016 May 21;7(25):38539–38550. doi: 10.18632/oncotarget.9533

Figure 8. SB203580 inhibits EMT and the expression of inflammatory factors in diabetic pancreatic cancer in vivo.

Figure 8

A. p38 MAPK phosphorylation and the protein expression levels of E-cadherin, vimentin, TNF-a, IL-6, p-NFκB, NFκB and cleaved caspase 3 in primary tumor tissues and metastatic lesions (intestinal metastatic sites) obtained from the WT, WT+SB, DM and DM+SB groups. B-H. Quantitation of the expression levels of the above proteins in the primary tumors from the different groups (n=5/group). P: primary lesion; M: metastatic lesion. * P < 0.05, ** P < 0.01, *** P < 0.001, ## P < 0.01, and ### P < 0.001.